Characteristic | CRE colonized patients (n = 340) | Non-colonized patients (n = 679) | P value |
---|---|---|---|
Male gender | 188 (55.3) | 399 (58.8) | 0.291 |
Age (matched) mean ± sd | 64 ± 18 | 64 ± 17 | 0.400 |
Hospital division (matched) | > 0.999 | ||
ICU | 67 (19.7) | 133 (19.6) | |
Hemato-oncology | 45 (13.2) | 90 (13.3) | |
Other | 228 (67.1) | 456 (67.2) | |
Residence in LTCF | 60 (17.6) | 83 (12.2) | 0.019* |
Diabetes mellitus | 134 (39.4) | 210 (30.9) | 0.007* |
Malignancy | 127 (37.4) | 305 (45.1) | 0.019* |
COPD | 29 (8.5) | 38 (5.6) | 0.078 |
Chronic kidney disease | 30 (8.8) | 55 (8.1) | 0.704 |
Liver disease | 21 (6.2) | 23 (3.4) | 0.039* |
Cerebrovascular disease | 36 (10.6) | 85 (12.6) | 0.361 |
Charlson’s comorbidity index median [IQR] | 3 [2–6] | 3 [2–5] | 0.290 |
Bedridden status | 136 (40.0) | 213 (31.5) | 0.007* |
Invasive ventilation | 86 (25.3) | 135 (19.9) | 0.048* |
Hemoglobin mean ± sd | 9.6 ± 1.8 | 10.4 ± 2.1 | < 0.001* |
Total antibiotic days in 90 days prior to index median [IQR] | 14 [7–24] | 6 [0–18] | < 0.001* |
Days of hospital stay in 90 days prior to index (matched) median [IQR] (matched) | 23 [12–37] | 20 [9–36] | 0.012*a |